Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pradigastat in Familial Chylomicronemia Syndrome
NCT01514461Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of pradigastat in familial chylomicronemia syndrome (FCS), sponsored by Novartis. Started Jul 2012; status: completed.
02
Drugs
pradigastat
03
Conditions
familial chylomicronemia syndrome (FCS)
Beyond the preview
Go deeper on NCT01514461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514461.